Trends in compassionate use of medicinal products: Israel 2020–2024
The study suggests that Israel's compassionate use programs have accelerated early access to novel therapies for complex conditions and provided a bridge to the inclusion of novel medicinal products in the national health basket. Nonetheless, the study identifies a concerning downward trend in utilization alongside potential access disparities, thereby underscoring the necessity for further targeted investigations.
Authors
- Segev Shani
- Mohammed Aboukaoud (ORCID: https://orcid.org/0000-0001-6991-9523)
- Eli Marom (ORCID: https://orcid.org/0000-0003-3210-3349)
- Eyal Schwartzberg (ORCID: https://orcid.org/0000-0002-8588-7223)
- Victoria Finkel-Pekarsky
- Miriam Cohen Kandli
Institutions
- Ben-Gurion University of the Negev (IL)
- Israel Ministry of Health (IL)
- Ernst & Young (Israel) (IL)
Publication Details
- Journal
- Israel Journal of Health Policy Research
- Published
- 2025-11-12
- DOI
- https://doi.org/10.1186/s13584-025-00730-3
- Primary Topic
- Biomedical Ethics and Regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00